Personal information

Other IDs

SciProfiles: 1243256
Scopus Author ID: 6508112093

Countries

Slovenia

Activities

Collapse all

Employment (2)

Splošna bolnišnica Slovenj Gradec: Slovenj Gradec, SI

2004-10-23 to present | Head (Fabry Center Slovenj Gradec)
Employment
Source: Self-asserted source
Bojan Vujkovac

Splošna bolnišnica Slovenj Gradec: Slovenj Gradec, SI

1998 to 2020-03-01 | Head (Dept. of Dialysis)
Employment
Source: Self-asserted source
Bojan Vujkovac

Education and qualifications (1)

Univerza v Ljubljani Medicinska Fakulteta: Ljubljana, SI

1980-10-01 to 1987-06-22
Education
Source: Self-asserted source
Bojan Vujkovac

Works (50 of 55)

Items per page:
Page 1 of 2

Telomere Length, Oxidative Stress, and Kidney Damage Biomarkers in Fabry Nephropathy

Cells
2025-02-04 | Journal article
DOI: 10.3390/cells14030218
Contributors: Tina Levstek; Erazem Bahčič; Bojan Vujkovac; Andreja Cokan Vujkovac; Tine Tesovnik; Žiga Iztok Remec; Vanja Čuk; Katarina Trebušak Podkrajšek
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Dynamics of Leukocyte Telomere Length in Patients with Fabry Disease

Biomedicines
2024-08-01 | Journal article
DOI: 10.3390/biomedicines12081724
Contributors: Tina Levstek; Nika Breznik; Bojan Vujkovac; Albina Nowak; Katarina Trebušak Podkrajšek
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Urinary-derived extracellular vesicles reveal a distinct microRNA signature associated with the development and progression of Fabry nephropathy.

Frontiers in medicine
2023-03-23 | Journal article
DOI: 10.3389/fmed.2023.1143905
PMID: 37035314
PMC: PMC10076752
Contributors: Levstek T; Vujkovac B; Cokan Vujkovac A; Trebušak Podkrajšek K
Source: Self-asserted source
Bojan Vujkovac

Renoprotective Effect of Agalsidase Alfa: A Long-Term Follow-Up of Patients with Fabry Disease

Journal of Clinical Medicine
2022-08-17 | Journal article
DOI: 10.3390/jcm11164810
Contributors: Markus Cybulla; Kathleen Nicholls; Sandro Feriozzi; Aleš Linhart; Joan Torras; Bojan Vujkovac; Jaco Botha; Christina Anagnostopoulou; Michael L. West
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

An expert consensus on practical clinical recommendations and guidance for patients with classic Fabry disease.

Molecular genetics and metabolism
2022-07-26 | Journal article
DOI: 10.1016/j.ymgme.2022.07.010
PMID: 35926321
Contributors: Germain DP; Altarescu G; Barriales-Villa R; Mignani R; Pawlaczyk K; Pieruzzi F; Terryn W; Vujkovac B; Ortiz A
Source: Self-asserted source
Bojan Vujkovac

Podocyturia in Fabry disease: a 10-year follow-up

Clinical Kidney Journal
2022-02-04 | Journal article
DOI: 10.1093/ckj/sfab172
Contributors: Bojan Vujkovac; Irena Srebotnik Kirbiš; Tajda Keber; Andreja Cokan Vujkovac; Martin Tretjak; Sandra Radoš Krnel
Source: check_circle
Crossref

Urinary Extracellular Vesicles and Their miRNA Cargo in Patients with Fabry Nephropathy

Genes
2021-07-09 | Journal article
DOI: 10.3390/genes12071057
Contributors: Tina Levstek; Teo Mlinšek; Marija Holcar; Katja Goričar; Metka Lenassi; Vita Dolžan; Bojan Vujkovac; Katarina Trebušak Podkrajšek
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Aging in Fabry Disease: Role of Telomere Length, Telomerase Activity, and Kidney Disease

Nephron
2020 | Journal article
DOI: 10.1159/000502909
WOSUID: WOS:000507641200002
Contributors: Vujkovac, Andreja Cokan; Novakovic, Srdjan; Vujkovac, Bojan; Stevanec, Milan; Skerl, Petra; Sabovic, Miso
Source: check_circle
Web of Science Researcher Profile Sync
grade
Preferred source (of 2)‎

Cardiomyopathy and kidney function in agalsidase beta-treated female Fabry patients: a pre-treatment vs. post-treatment analysis

ESC Heart Failure
2020 | Journal article
DOI: 10.1002/EHF2.12647
WOSUID: WOS:000515687100001
Contributors: Wanner, Christoph; Feldt-Rasmussen, Ulla; Jovanovic, Ana; Linhart, Ales; Yang, Meng; Ponce, Elvira; Brand, Eva; Germain, Dominique P.; Hughes, Derralynn A.; Jefferies, John L. et al.
Source: check_circle
Web of Science Researcher Profile Sync
grade
Preferred source (of 2)‎

Switching from agalsidase alfa to pegunigalsidase alfa for treating Fabry disease: One year of treatment data from BRIDGE, a phase III open label study

Molecular Genetics and Metabolism
2020 | Journal article
DOI: 10.1016/J.YMGME.2019.11.249
WOSUID: WOS:000510805200259
Contributors: Linhart, Ales; Dostalova, Gabriela; Nicholls, Kathy; West, Michael; Tendel, Camilla; Jovanovic, Ana; Giraldo, Pilar; Vujkovac, Bojan; Hiwot, Tarekegn; Brill-Almon, Einat et al.
Source: check_circle
Web of Science Researcher Profile Sync

Characteristics of Vascular Phenotype in Fabry Patients.

Angiology
2020-12-21 | Journal article
DOI: 10.1177/0003319720981521
PMID: 33342225
Source: Self-asserted source
Bojan Vujkovac
grade
Preferred source (of 2)‎

Early indicators of disease progression in Fabry disease that may indicate the need for disease-specific treatment initiation: findings from the opinion-based PREDICT-FD modified Delphi consensus initiative.

BMJ open
2020-10-10 | Journal article
DOI: 10.1136/bmjopen-2019-035182
PMID: 33039984
PMC: PMC7549469
Source: Self-asserted source
Bojan Vujkovac
grade
Preferred source (of 2)‎

Biomarkers of Fabry Nephropathy: Review and Future Perspective.

Genes
2020-09-18 | Journal article
DOI: 10.3390/genes11091091
PMID: 32962051
PMC: PMC7564978
Source: Self-asserted source
Bojan Vujkovac
grade
Preferred source (of 3)‎

Analysis of the baseline characteristics of Fabry disease patients screened for the pegunigalsidase alfa phase III BALANCE study

Molecular Genetics and Metabolism
2019 | Journal article
DOI: 10.1016/J.YMGME.2018.12.389
WOSUID: WOS:000457351700375
Contributors: Warnock, David; Warnock, David; Eric, Wallace; Eric, Wallace; Schiffmann, Raphael; Schiffmann, Raphael; Holida, Myrl; Holida, Myrl; Goker-Alpan, Ozlem; Goker-Alpan, Ozlem et al.
Source: check_circle
Web of Science Researcher Profile Sync

Pegunigalsidase alfa for the treatment of Fabry disease: Preliminary results from a phase III open label, switch over study from agalsidase alfa

Molecular Genetics and Metabolism
2019 | Journal article
DOI: 10.1016/J.YMGME.2018.12.234
WOSUID: WOS:000457351700220
Contributors: Linhart, Ales; Nicholls, Kathy; West, Michael; Tondel, Camilla; Jovanovic, Ana; Giraldo, Pilar; Vujkovac, Bojan; Almon, Einat; Alon, Sari; Amit-Cohen, Bat-chen et al.
Source: check_circle
Web of Science Researcher Profile Sync

Renal and cardiac outcomes in female patients with Fabry disease treated with agalsidase beta: A Fabry registry analysis of pre-versus post-treatment comparison

Molecular Genetics and Metabolism
2019 | Journal article
DOI: 10.1016/J.YMGME.2018.12.388
WOSUID: WOS:000457351700374
Contributors: Wanner, Christoph; Feldt-Rasmussen, Ulla; Jovanovic, Ana; Linhart, Ales; Yang, Meng; Brand, Eva; Germain, Dominique P.; Hughes, Derralynn A.; Jefferies, John L.; Martins, Ana M. et al.
Source: check_circle
Web of Science Researcher Profile Sync

RENOPROTECTIVE EFFECT OF AGALSIDASE ALFA IN FABRY DISEASE IS INDEPENDENT OF TYPE OF MUTATION: RESULTS OF 12-YEAR FOLLOW-UP

Nephrology Dialysis Transplantation
2019 | Journal article
WOSUID: WOS:000495412900199
Contributors: Cybulla, Markus; Nicholls, Kathleen; Feriozzi, Sandro; Torras, Joan; Vujkovac, Bojan; Gurevich, Andrey; Kalampoki, Vasiliki; West, Michael L.
Source: check_circle
Web of Science Researcher Profile Sync

Fabry disease: diagnostic methods in nephrology practice

Clinical Nephrology
2017 | Journal article
DOI: 10.5414/CNP88FX28
WOSUID: WOS:000418445000011
Contributors: Vujkovac, Bojan
Source: check_circle
Web of Science Researcher Profile Sync
grade
Preferred source (of 2)‎

Paricalcitol as an Antiproteinuric Agent Can Result in the Deterioration of Renal and Heart Function in a Patient with Fabry Disease

American Journal of Case Reports
2017 | Journal article
DOI: 10.12659/AJCR.903886
WOSUID: WOS:000403180000001
Contributors: Keber, Tajda; Tretjak, Martin; Vujkovac, Andreja Cokan; Mravljak, Marija; Ravber, Katja; Vujkovac, Bojan
Source: check_circle
Web of Science Researcher Profile Sync
grade
Preferred source (of 2)‎

Anti-proteinuric therapy and Fabry nephropathy; factors associated with preserved kidney function during agalsidase-beta therapy

Molecular Genetics and Metabolism
2016 | Journal article
DOI: 10.1016/J.YMGME.2015.12.484
WOSUID: WOS:000370888100327
Contributors: Warnock, David G.; Thomas, Christie P.; Vujkovac, Bojan; Campbell, Ruth C.; Charrow, Joel; Laney, Dawn A.; Jackson, Leslie L.; Wilcox, William R.; Wanner, Christoph
Source: check_circle
Web of Science Researcher Profile Sync

Renal Replacement Therapy in Slovenia: Excerpts From 2013 Data

Therapeutic Apheresis and Dialysis
2016 | Journal article
DOI: 10.1111/1744-9987.12427
WOSUID: WOS:000379149300002
Contributors: Buturovic-Ponikvar, Jadranka; Buturovic-Ponikvar, Jadranka; Gubensek, Jakob; Gubensek, Jakob; Arnol, Miha; Arnol, Miha; Adamlje, Tone; Adamlje, Tone; Ceglar, Zlata; Ceglar, Zlata et al.
Source: check_circle
Web of Science Researcher Profile Sync
grade
Preferred source (of 2)‎

Antiproteinuric therapy and Fabry nephropathy: factors associated with preserved kidney function during agalsidase-beta therapy

Journal of Medical Genetics
2015 | Journal article
DOI: 10.1136/JMEDGENET-2015-103471
WOSUID: WOS:000366970000010
Contributors: Warnock, David G.; Thomas, Christie P.; Vujkovac, Bojan; Campbell, Ruth C.; Charrow, Joel; Laney, Dawn A.; Jackson, Leslie L.; Wilcox, William R.; Wanner, Christoph
Source: check_circle
Web of Science Researcher Profile Sync
grade
Preferred source (of 2)‎

Exocrine pancreatic insufficiency is not a cause of abdominal complaints in patients with Fabry disease

Wiener Klinische Wochenschrift
2015 | Journal article
DOI: 10.1007/S00508-015-0731-9
WOSUID: WOS:000366649600005
Contributors: Vujasinovic, Miroslav; Tepes, Bojan; Vujkovac, Bojan; Vujkovac, Andreja Cokan; Tretjak, Martin; Korat, Vesna
Source: check_circle
Web of Science Researcher Profile Sync
grade
Preferred source (of 2)‎

Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document

Orphanet Journal of Rare Diseases
2015 | Journal article
DOI: 10.1186/S13023-015-0253-6
WOSUID: WOS:000351990100001
Contributors: Biegstraaten, Marieke; Arngrimsson, Reynir; Barbey, Frederic; Boks, Lut; Cecchi, Franco; Deegan, Patrick B.; Feldt-Rasmussen, Ulla; Geberhiwot, Tarekegn; Germain, Dominique P.; Hendriksz, Chris et al.
Source: check_circle
Web of Science Researcher Profile Sync
grade
Preferred source (of 2)‎

Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy in adults with Fabry disease.

Drug design, development and therapy
2015-07-08 | Journal article
DOI: 10.2147/dddt.s80928
PMID: 26185417
PMC: PMC4501226
Source: Self-asserted source
Bojan Vujkovac
grade
Preferred source (of 2)‎

Recommendations on Reintroduction of Agalsidase Beta for Patients with Fabry Disease in Europe, Following a Period of Shortage

JIMD reports
2013 | Journal article
DOI: 10.1007/8904_2012_160
WOSUID: WOS:000315959400009
Contributors: Linthorst, Gabor E.; Burlina, Alessandro P.; Cecchi, Franco; Cox, Timothy M.; Fletcher, Janice M.; Feldt-Rasmussen, Ulla; Giugliani, Roberto; Hollak, Carla E. M.; Houge, Gunnar; Hughes, Derralynn et al.
Source: check_circle
Web of Science Researcher Profile Sync
grade
Preferred source (of 2)‎

Renal Replacement Therapy in Slovenia: Excerpts From 2011 Data

Therapeutic Apheresis and Dialysis
2013 | Journal article
DOI: 10.1111/1744-9987.12078
WOSUID: WOS:000322917100002
Contributors: Buturovic-Ponikvar, Jadranka; Gubensek, Jakob; Arnol, Miha; Adamlje, Tone; Blanusa, Danica; Ceglar, Zlata; Steklasa, Sonja Cimerman; Cerne, Senka; Cufer, Andrej; Drozg, Andrej et al.
Source: check_circle
Web of Science Researcher Profile Sync
grade
Preferred source (of 2)‎

THE FABRAZYME (R), ANGIOTENSIN RECEPTOR BLOCKER AND ACE INHIBITOR TREATMENT STUDY FOR FABRY NEPHROPATHY (FOR THE FAACET INVESTIGATORS)

Nephrology Dialysis Transplantation
2013 | Journal article
WOSUID: WOS:000319498201503
Contributors: Warnock, David; Guasch, Antonio; Thomas, Christie; Wanner, Christoph; Campbell, Ruth; Vujkovac, Bojan
Source: check_circle
Web of Science Researcher Profile Sync

Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation

Nephrology Dialysis Transplantation
2012 | Journal article
DOI: 10.1093/NDT/GFR420
WOSUID: WOS:000301907200030
Contributors: Warnock, David G.; Ortiz, Alberto; Mauer, Michael; Linthorst, Gabor E.; Oliveira, Joao P.; Serra, Andreas L.; Marodi, Laszlo; Mignani, Renzo; Vujkovac, Bojan; Beitner-Johnson, Dana et al.
Source: check_circle
Web of Science Researcher Profile Sync
grade
Preferred source (of 2)‎

Association Between Platelet-Related Hemostasis Impairment and Functional Iron Deficiency in Hemodialysis Patients

Therapeutic Apheresis and Dialysis
2011 | Journal article
DOI: 10.1111/J.1744-9987.2010.00853.X
WOSUID: WOS:000286741600005
Contributors: Zupan, Irena P.; Sabovic, Miso; Salobir, Barbara; Ponikvar, Jadranka B.; Cernelc, Peter; Lavre, Janez; Vujkovac, Bojan
Source: check_circle
Web of Science Researcher Profile Sync
grade
Preferred source (of 2)‎

Could Iron Deficiency Also Affect Platelet-Related Hemostasis Impairment in Hemodialysis Patients?: Reply

Therapeutic Apheresis and Dialysis
2011 | Journal article
DOI: 10.1111/J.1744-9987.2011.00991.X
WOSUID: WOS:000294215200018
Contributors: Zupan, Irena; Sabovic, Miso; Salobir, Barbara; Buturovic-Ponikvar, Jadranka; Cernelc, Peter; Lavre, Janez; Vujkovac, Bojan
Source: check_circle
Web of Science Researcher Profile Sync
grade
Preferred source (of 2)‎

Urinary Total Globotriaosylceramide and Isoforms to Identify Women With Fabry Disease: A Diagnostic Test Study

American Journal of Kidney Diseases
2011 | Journal article
DOI: 10.1053/J.AJKD.2010.10.046
WOSUID: WOS:000289513600009
Contributors: Paschke, Eduard; Fauler, Guenter; Winkler, Heimo; Schlagenhauf, Axel; Plecko, Barbara; Erwa, Wolfgang; Breunig, Frank; Urban, Wolfgang; Vujkovac, Bojan; Sunder-Plassmann, Gere et al.
Source: check_circle
Web of Science Researcher Profile Sync
grade
Preferred source (of 2)‎

VASCULAR ACCESS FOR HEMODIALYSIS PATIENTS IN SLOVENIA - DATA FROM THE SLOVENIAN RENAL REPLACEMENT THERAPY REGISTRY

The International Journal of Artificial Organs
2011 | Journal article
WOSUID: WOS:000299017900282
Contributors: Ponikvar, J. Buturovid; Adamlje, L.; Blanusa, D.; Ceglar, Z.; Cimerman-Steklasa, S.; Cuter, A.; Drozg, A.; Ekart, R.; Gutek, A.; Kandus, A. et al.
Source: check_circle
Web of Science Researcher Profile Sync

End stage renal disease in patients with Fabry disease: Natural history data from the Fabry registry

Molecular Genetics and Metabolism
2010 | Journal article
DOI: 10.1016/J.YMGME.2009.10.160
WOSUID: WOS:000274004300156
Contributors: Warnock, David; Ortiz, Alberto; Cianciaruso, Bruno; Cizmarik, Marta; Germain, Dominique; Mignani, Renzo; Oliveira, Joao Paulo; Villalobos, Jacobo; Vujkovac, Bojan; Waldek, Stephen et al.
Source: check_circle
Web of Science Researcher Profile Sync

End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry

Nephrology Dialysis Transplantation
2010 | Journal article
DOI: 10.1093/NDT/GFP554
WOSUID: WOS:000274987800020
Contributors: Ortiz, Alberto; Cianciaruso, Bruno; Cizmarik, Marta; Germain, Dominique P.; Mignani, Renzo; Oliveira, Joao Paulo; Villalobos, Jacobo; Vujkovac, Bojan; Waldek, Stephen; Wanner, Christoph et al.
Source: check_circle
Web of Science Researcher Profile Sync
grade
Preferred source (of 2)‎

NATURAL HISTORY OF END-STAGE RENAL DISEASE IN PATIENTS ENROLLED IN THE FABRY REGISTRY

Clinical Therapeutics
2010 | Journal article
WOSUID: WOS:000281215400015
Contributors: Ortiz, Alberto; Cianciaruso, Bruno; Cizmarik, Marta; Germain, Dominique P.; Mignani, Renzo; Oliveira, Joao Paulo; Villalobos, Jacobo; Vujkovac, Bojan; Waldek, Stephen; Wanner, Christoph et al.
Source: check_circle
Web of Science Researcher Profile Sync

Prognostic Indicators of Renal Disease Progression in Adults with Fabry Disease: Natural History Data from the Fabry Registry

Clinical Journal of the American Society of Nephrology
2010 | Journal article
DOI: 10.2215/CJN.04340510
WOSUID: WOS:000285080100014
Contributors: Wanner, Christoph; Wanner, Christoph; Oliveira, Joao P.; Oliveira, Joao P.; Ortiz, Alberto; Ortiz, Alberto; Mauer, Michael; Mauer, Michael; Germain, Dominique P.; Germain, Dominique P. et al.
Source: check_circle
Web of Science Researcher Profile Sync
grade
Preferred source (of 2)‎

Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN)

Nephrology Dialysis Transplantation
2010 | Journal article
DOI: 10.1093/NDT/GFP528
WOSUID: WOS:000279189400021
Contributors: Fogo, Agnes B.; Bostad, Leif; Svarstad, Einar; Cook, William J.; Moll, Solange; Barbey, Federic; Geldenhuys, Laurette; West, Michael; Ferluga, Dusan; Vujkovac, Bojan et al.
Source: check_circle
Web of Science Researcher Profile Sync
grade
Preferred source (of 2)‎

SCORING SYSTEM FOR RENAL PATHOLOGY IN FABRY DISEASE: REPORT OF THE INTERNATIONAL STUDY GROUP OF FABRY NEPHROPATHY (ISGFN)

Clinical Therapeutics
2010 | Journal article
WOSUID: WOS:000281215400017
Contributors: Oliveira, Joao Paulo; Fogo, Agnes B.; Bostad, Leif; Svarstad, Einar; Cook, William J.; Moll, Solange; Barbey, Federic; Geldenhuys, Laurette; West, Michael; Ferluga, Dusan et al.
Source: check_circle
Web of Science Researcher Profile Sync

Female fabry patients can be discriminated from healthy and nephropathic non-fabry subjects by an analysis of globotriaosylceramide isoforms in urine

Nephrology Dialysis Transplantation
2007 | Journal article
WOSUID: WOS:000253320600076
Contributors: Paschke, Eduard; Fauler, Guenter; Urban, Wolfgang; Plecko, Barbara; Erwa, Wolfgang; Vujkovac, Bojan; Breunig, Frank; Sunder-Plassmann, Gere; Kotanko, Peter
Source: check_circle
Web of Science Researcher Profile Sync

A successful treatment of life-threatening bleeding from polycystic kidneys with antifibrinolytic agent tranexamic acid

Blood Coagulation & Fibrinolysis
2006 | Journal article
DOI: 10.1097/01.MBC.0000245293.41774.C8
WOSUID: WOS:000245418600014
Contributors: Vujkovac, Bojan; Sabovic, Miso
Source: check_circle
Web of Science Researcher Profile Sync
grade
Preferred source (of 2)‎

Effect of angiotensin-converting enzyme inhibitors on proteinuria in patients with Fabry disease treated with enzyme replacement therapy

Acta Paediatrica
2006 | Journal article
WOSUID: WOS:000237456700063
Contributors: Vujkovac, B; Cokan, A; Verovnik, F; Benko, D; Sabovic, M
Source: check_circle
Web of Science Researcher Profile Sync

ASSOCIATION BETWEEN HEMOSTASIS IMPAIRMENT AND FUNCTIONAL IRON DEFICIENCY IN HEMODIALYSIS PATIENTS

Nephrology
2005 | Journal article
WOSUID: WOS:000208633501325
Contributors: Zupan, Irena Preloznik; Sabovic, Miso; Salobir, Barbara; Ponikvar, Jadranka Buturovic; Cernelic, Peter; Lavre, Janez; Vujkovac, Bojan
Source: check_circle
Web of Science Researcher Profile Sync

EFFECT OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS ON PROTEINURIA IN PATIENTS WITH FABRY DISEASE TREATED WITH ENZYME REPLACEMENT THERAPY

Nephrology
2005 | Journal article
WOSUID: WOS:000208633500852
Contributors: Vujkovac, Bojan; Cokan, Andreja; Verovnik, Franc; Sabovic, Miso; Benko, Davorin
Source: check_circle
Web of Science Researcher Profile Sync

EFFECT OF ENZYME REPLACEMENT THERAPY ON ENDOTHELIAL FUNCTION IN PATIENTS WITH FABRY DISEASE

Nephrology
2005 | Journal article
WOSUID: WOS:000208633500853
Contributors: Cokan, Andreja; Rainer, Sasa; Vujkovac, Bojan; Verovnik, Franc; Benko, Davorin; Sabovic, Miso
Source: check_circle
Web of Science Researcher Profile Sync

Epoetin responsiveness in peritoneal dialysis patients: A multi-center Slovenian study

Therapeutic Apheresis and Dialysis
2005 | Journal article
DOI: 10.1111/J.1774-9987.2005.00260.X
WOSUID: WOS:000230878400010
Contributors: Pajek, J; Pajek, J; Bucar-Pajek, M; Bucar-Pajek, M; Grego, K; Grego, K; Gucek, A; Gucek, A; Bevc, S; Bevc, S et al.
Source: check_circle
Web of Science Researcher Profile Sync
grade
Preferred source (of 2)‎

PERITONEAL DIALYSIS AFTER ABDOMINAL SURGERY WITH LOW VOLUME EXCHANGE PROTOCOL

Nephrology
2005 | Journal article
WOSUID: WOS:000208633500271
Contributors: Vujkovac, Bojan; Plesivcnik, Zala; Lavre, Janez; Pecolar, Sonja
Source: check_circle
Web of Science Researcher Profile Sync

The effect of long term, low-dose tranexamic acid treatment on platelet dysfunction and haemoglobin levels in haemodialysis patients

Thrombosis and Haemostasis
2005 | Journal article
DOI: 10.1160/TH05-02-0123
WOSUID: WOS:000234214900022
Contributors: Sabovic, M; Zupan, IP; Salobir, B; Zupan, I; Cernelc, P; Lavre, J; Vujkovac, B
Source: check_circle
Web of Science Researcher Profile Sync
grade
Preferred source (of 2)‎

The study of anaemia-related haemostasis impairment in haemodialysis patients by in vitro closure time test

Nephrology Dialysis Transplantation
2005 | Journal article
DOI: 10.1160/TH04-08-0529
WOSUID: WOS:000234376901406
Contributors: Zupan, IP; Abovic, M; Salobir, B; Ponikvar, JB; Cernelc, P; Lavre, J; Vujkovac, B
Source: check_circle
Web of Science Researcher Profile Sync
grade
Preferred source (of 2)‎

Remarkable variability in renal disease in a large Slovenian family with Fabry disease

European Journal of Human Genetics
2004 | Journal article
DOI: 10.1038/SJ.EJHG.5201184
WOSUID: WOS:000222815000014
Contributors: Verovnik, F; Benko, D; Vujkovac, B; Linthorst, GE
Source: check_circle
Web of Science Researcher Profile Sync
grade
Preferred source (of 2)‎
Items per page:
Page 1 of 2

Peer review (12 reviews for 4 publications/grants)

Review activity for BMC nephrology (1)
Review activity for F1000Research. (1)
Review activity for Journal of rare diseases. (1)
Review activity for Nephron journals. (9)
How many people are using ORCID?